Effects of Huperzine A in Treatment of Moderate to Severe TBI
Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
We will explore the use of Huperzine A in patients who have sustained a moderate to severe
Traumatic Brain Injury. We aim to determine whether Huperzine A, as compared with placebo,
would have an effect on memory function after TBI. Additionally, we aim to determine whether
use of Huperzine A in these patients can change brain activity (as indexed by EEG and
Transcranial Magnetic Stimulation - TMS), and reduce prevalence/frequency of post-traumatic
seizures. We also aim to evaluate the safety of Huperzine A in this population as compared
with placebo.